Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Editas Medicine Inc’s current trading price is -52.01% away from its 52-week high, while its distance from the 52-week low is 26.07%.
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Editas Medicine Inc’s current trading price is -54.66% away from its 52-week high, while its distance from the 52-week low is 19.10%.
Editas Medicine Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $11.69 on 12/06/23, while the lowest price for the same duration was marked at $4.78 on 06/27/24. 52-week price history of EDIT Stock
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -50.21% this year. Over the last six months, there has been
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -40.38%. However, over the past six months, we’ve seen a stronger performance of -39.05%. The
In the biotechnology industry, tools for diagnosing health problems and mechanisms for treating them are developed. Biotech products typically require a significant amount of research and funding before they are approved by the FDA (Food and Drug Administration). A drug’s profitability is often discovered years
All rights reserved © 2024, Powered By Smart TechOne
